@prefix fhir: <http://hl7.org/fhir/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

# - resource -------------------------------------------------------------------

<http://hl7.org/fhir/uv/pharm-quality/Composition/composition-drug-pq-risk> a fhir:Composition ;
  fhir:nodeRole fhir:treeRoot ;
  fhir:id [ fhir:v "composition-drug-pq-risk"] ; # 
  fhir:meta [
     fhir:profile ( [
       fhir:v "http://hl7.org/fhir/uv/pharm-quality/StructureDefinition/Composition-drug-pq"^^xsd:anyURI ;
       fhir:l <http://hl7.org/fhir/uv/pharm-quality/StructureDefinition/Composition-drug-pq>
     ] )
  ] ; # 
  fhir:language [ fhir:v "en"] ; # 
  fhir:text [
     fhir:status [ fhir:v "generated" ] ;
     fhir:div [ fhir:v "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: Composition composition-drug-pq-risk</b></p><a name=\"composition-drug-pq-risk\"> </a><a name=\"hccomposition-drug-pq-risk\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-Composition-drug-pq.html\">Composition - Drug PQ</a></p></div><p><b>status</b>: Final</p><p><b>type</b>: <span title=\"Codes:\">Product Note - Summary for Risk of Impurities</span></p><p><b>date</b>: 2023-10-01</p><p><b>author</b>: <a href=\"Organization-organization-drug-pq-ex1.html\">Organization AAA Molybdenum Products, Inc.</a></p><p><b>title</b>: 3.2.P.2.2.4 - Summary for Risk of Impurities</p></div>"^^rdf:XMLLiteral ]
  ] ; # 
  fhir:status [ fhir:v "final"] ; # 
  fhir:type [
     fhir:text [ fhir:v "Product Note - Summary for Risk of Impurities" ]
  ] ; # 
  fhir:subject ( [
     fhir:l <http://hl7.org/fhir/uv/pharm-quality/MedicinalProductDefinition/medicinalproductdefinition-drug-product-pq-ex1> ;
     fhir:reference [ fhir:v "MedicinalProductDefinition/medicinalproductdefinition-drug-product-pq-ex1" ]
  ] ) ; # 
  fhir:date [ fhir:v "2023-10-01"^^xsd:date] ; # 
  fhir:author ( [
     fhir:l <http://hl7.org/fhir/uv/pharm-quality/Organization/organization-drug-pq-ex1> ;
     fhir:reference [ fhir:v "Organization/organization-drug-pq-ex1" ]
  ] ) ; # 
  fhir:title [ fhir:v "3.2.P.2.2.4 - Summary for Risk of Impurities"] ; # 
  fhir:section ( [
     fhir:text [
       fhir:status [ fhir:v "additional" ] ;
       fhir:div [ fhir:v "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Text for the risk assessment of elemental impurities in the product</p></div>"^^rdf:XMLLiteral ]
     ]
  ] ) . # 

<http://hl7.org/fhir/uv/pharm-quality/MedicinalProductDefinition/medicinalproductdefinition-drug-product-pq-ex1> a fhir:Uv .

<http://hl7.org/fhir/uv/pharm-quality/Organization/organization-drug-pq-ex1> a fhir:Uv .

# -------------------------------------------------------------------------------------